J. Brown, C. Grudzen, D. N. Kyriacou, Z. Obermeyer, T. Quest et al., The Emergency Care of Patients with Cancer: Setting the Research Agenda, Ann Emerg Med, vol.68, pp.706-717, 2016.

S. J. Sammut and D. Mazhar, Management of febrile neutropenia in an acute oncology service, QJM, vol.105, pp.327-363, 2012.

T. Perron, M. Emara, and S. Ahmed, Time to antibiotics and outcomes in cancer patients with febrile neutropenia, BMC Health Serv Res, vol.14, p.162, 2014.

J. J. Lynn, K. F. Chen, Y. M. Weng, and T. F. Chiu, Risk factors associated with complications in patientswith chemotherapy-induced febrile neutropenia in emergency department, Hematol Oncol, vol.31, pp.189-96, 2013.

M. K. Keng, E. A. Thallner, P. Elson, C. Ajon, J. Sekeres et al., Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department, J Oncol Pract, vol.11, pp.450-455, 2015.

B. S. Ko, S. Ahn, Y. S. Lee, W. Y. Kim, K. S. Lim et al., Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia, Support Care Cancer, vol.23, p.25663578, 2015.

L. M. Daniels, U. Durani, J. N. Barreto, J. C. O'horo, M. A. Siddiqui et al., Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia

A. G. Freifeld, E. J. Bow, K. A. Sepkowitz, M. J. Boeckh, J. I. Ito et al., Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America, Clin Infect Dis, vol.52, pp.56-93, 2011.

D. Averbuch, C. Orasch, C. Cordonnier, D. M. Livermore, M. Mikulska et al., European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the, 4th European Conference on Infections in Leukemia, vol.98, pp.1826-1861, 2011.

J. D. Wright, A. I. Neugut, C. V. Ananth, S. N. Lewin, E. T. Wilde et al., Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes, JAMA Intern Med, vol.173, pp.559-68, 2013.

J. Klastersky, M. Paesmans, E. B. Rubenstein, M. Boyer, L. Elting et al., The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients, J Clin Oncol, vol.18, pp.3038-51, 2000.

C. J. Coyne, V. Le, J. J. Brennan, E. M. Castillo, R. A. Shatsky et al., Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk FebrileNeutropenic Patients in the Emergency Department, Ann Emerg Med, vol.69, pp.755-64, 2017.

S. Chevret, S. Seaman, and M. Resche-rigon, Multiple imputation: a mature approach to dealing with missing data, Intensive Care Med, vol.41, p.25578679, 2015.

I. R. White, P. Royston, and A. M. Wood, Multiple imputation using chained equations: Issues and guidance for practice, Stat Med, vol.30, pp.377-99, 2011.

. Idsa-sepsis-task-force, Infectious Diseases Society of America (IDSA) POSITION STATEMENT: Why IDSA Did Not Endorse the Surviving Sepsis Campaign Guidelines, Clin Infect Dis, vol.66, pp.1631-1636, 2018.

A. Rhodes, L. E. Evans, W. Alhazzani, M. M. Levy, M. Antonelli et al., Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016, Intensive Care Med, vol.43, p.28101605, 2017.

Y. Freund, A. Khoury, M. Möckel, M. Karamercan, C. Dodt et al., European Society of Emergency Medicine position paper on the 1-hour sepsis bundle of the Surviving Sepsis Campaign: expression of concern, Eur J Emerg Med, vol.26, pp.232-235, 2019.

R. G. Rosa and L. Z. Goldani, Cohort study of the impact of time to antibiotic administration on mortality in patients with febrile neutropenia, Antimicrob Agents Chemother, vol.58, pp.2561-2575, 2014.

D. Mokart, C. Saillard, A. Sannini, L. Chow-chine, J. P. Brun et al., Neutropenic cancer patients with severe sepsis: need for antibiotics in the first hour, Intensive Care Med, vol.40, p.24966064, 2014.

J. Larche, E. Azoulay, F. Fieux, L. Mesnard, D. Moreau et al., Improved survival of critically ill cancer patients with septic shock, Intensive Care Med, vol.29, p.13680115, 2003.

R. A. Taplitz, E. B. Kennedy, E. J. Bow, J. Crews, C. Gleason et al., Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update, J Clin Oncol, vol.36, pp.1443-53, 2018.

M. Legrand, A. Max, V. Peigne, E. Mariotte, E. Canet et al., Survival in neutropenic patients with severe sepsis or septic shock, Crit Care Med, vol.40, pp.43-52, 2012.

G. Martinez-nadal, P. Puerta-alcalde, C. Gudiol, C. Cardozo, A. Albasanz-puig et al., Inappropriate Empirical Antibiotic Treatment in High-risk Neutropenic Patients With Bacteremia in the Era of Multidrug Resistance, Clin Infect Dis, 2019.

O. Peyrony, G. Dumas, L. Legay, A. Principe, J. Franchitti et al., Central venous oxygen saturation is not predictive of early complications in cancer patients presenting to the emergency department, Intern Emerg Med, vol.14, p.30306323, 2019.

E. Azoulay, D. Mokart, F. Pène, J. Lambert, A. Kouatchet et al., Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium-a groupe de recherche respiratoire en ré animation onco-hématologique study, J Clin Oncol, vol.31, pp.2810-2818, 2013.

E. Azoulay, F. Pène, M. Darmon, E. Lengliné, D. Benoit et al., Managing critically Ill hematology patients: Time to think differently, Blood Rev, vol.29, pp.359-67, 2015.

A. K. Kristensen, J. G. Holler, J. Hallas, A. Lassen, and N. I. Shapiro, Is shock index a valid predictor of mortality in emergency department patients with hypertension, diabetes, high age, or receipt of ?-or calcium channel blockers?, Ann Emerg Med, vol.67, pp.106-119, 2016.

T. Berger, J. Green, T. Horeczko, Y. Hagar, N. Garg et al., Shock index and early recognition of sepsis in the emergency department: pilot study, West J Emerg Med, vol.14, pp.168-74, 2013.

M. Kim, S. Ahn, W. Y. Kim, C. H. Sohn, D. W. Seo et al., Predictive performance of the quick Sequential Organ Failure Assessment score as a screening tool for sepsis, mortality, and intensive care unit admission in patients with febrile neutropenia, Support Care Cancer, vol.25, p.28062972, 2017.

A. Uys, B. Rapoport, and R. Anderson, Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score, Support Care Cancer, vol.12, p.15197637, 2004.

H. Innes, S. L. Lim, A. Hall, S. Y. Chan, N. Bhalla et al., Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice, Support Care Cancer, vol.16, p.17899215, 2008.

L. De-souza-viana, J. C. Serufo, M. O. Da-costa-rocha, R. N. Costa, and R. C. Duarte, Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients, Support Care Cancer, vol.16, p.17960431, 2008.

N. D. Baskaran, G. G. Gan, and K. Adeeba, Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients, Ann Hematol, vol.87, pp.563-572, 2008.

R. Lilford, A. Edwards, A. Girling, T. Hofer, D. Tanna et al., Inter-rater reliability of case-note audit: a systematic review, J Health Serv Res Policy, vol.12, pp.173-80, 2007.